TORONTO — Valeant Pharmaceuticals International said on Monday it has withdrawn its sweetened takeover bid for ISTA Pharmaceuticals Inc, citing a lack of progress. “We were not interested in par… more →
Financial Post | Businesswrote 1 year ago: TORONTO — Valeant Pharmaceuticals International said on Monday it has withdrawn its sweetened takeov … more →
wrote 1 year ago: TORONTO — Valeant Pharmaceuticals International Inc said on Friday it has submitted an unsolicited U … more →
wrote 1 year ago: Following on heavy losses at the end of Monday’s trading session, U.S. markets were initially … more →
wrote 1 year ago: Valeant Pharmaceuticals International Inc. said Tuesday it has taken control of Afexa Life Sciences … more →
wrote 1 year ago: The battle for Cold-FX maker Afexa Life Sciences Inc. appears to be coming to an end as one of its r … more →
wrote 1 year ago: The bidding war for Cold-FX flu remedy maker Afexa Life Sciences Inc. is getting hot and heavy, with … more →
wrote 1 year ago: MONTREAL — Cold-FX maker Afexa Life Sciences Inc. has found a white knight to fend off a hostile bid … more →
wrote 1 year ago: MONTREAL — Millions of people around the world are constantly getting sore throats and runny n … more →
wrote 1 year ago: Firing the latest salvo in a heated Canadian pharmaceutical battle, Afexa Life Sciences Inc.’s … more →
wrote 1 year ago: Pharmaceutical company Paladin Labs Inc. continued its buying spree Wednesday, announcing plans to a … more →
wrote 1 year ago: Following the break down of friendly talks with Afexa Life Sciences Inc., Paladin Labs Inc. has laun … more →
wrote 1 year ago: COLD-FX has another believer in Paladin Labs Inc., which announced an equity investment in Afexa Lif … more →